SK89198A3 - Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives - Google Patents

Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives Download PDF

Info

Publication number
SK89198A3
SK89198A3 SK891-98A SK89198A SK89198A3 SK 89198 A3 SK89198 A3 SK 89198A3 SK 89198 A SK89198 A SK 89198A SK 89198 A3 SK89198 A3 SK 89198A3
Authority
SK
Slovakia
Prior art keywords
oxo
hydroxy
formula
difluoro
tetrahydrofuran
Prior art date
Application number
SK891-98A
Other languages
English (en)
Slovak (sk)
Inventor
Keith Biggadike
Panayiotis A Procopiou
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9526651.6A external-priority patent/GB9526651D0/en
Priority claimed from GBGB9613121.4A external-priority patent/GB9613121D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SK89198A3 publication Critical patent/SK89198A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK891-98A 1995-12-29 1996-12-19 Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives SK89198A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9526651.6A GB9526651D0 (en) 1995-12-29 1995-12-29 Compounds
GBGB9613121.4A GB9613121D0 (en) 1996-06-21 1996-06-21 Compounds
PCT/GB1996/003140 WO1997024365A1 (en) 1995-12-29 1996-12-19 Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives

Publications (1)

Publication Number Publication Date
SK89198A3 true SK89198A3 (en) 1999-03-12

Family

ID=26308402

Family Applications (1)

Application Number Title Priority Date Filing Date
SK891-98A SK89198A3 (en) 1995-12-29 1996-12-19 Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives

Country Status (33)

Country Link
US (1) US6197761B1 (de)
EP (1) EP0876392B1 (de)
JP (1) JP2947944B2 (de)
KR (1) KR19990076859A (de)
CN (1) CN1133643C (de)
AP (1) AP9801274A0 (de)
AT (1) ATE194356T1 (de)
AU (1) AU721865B2 (de)
BG (1) BG102625A (de)
BR (1) BR9612309A (de)
CA (1) CA2241728A1 (de)
CZ (1) CZ207498A3 (de)
DE (1) DE69609199T2 (de)
DK (1) DK0876392T3 (de)
EA (1) EA001401B1 (de)
EE (1) EE9800227A (de)
ES (1) ES2150150T3 (de)
GR (1) GR3034564T3 (de)
HU (1) HUP9903707A3 (de)
IL (1) IL124938A0 (de)
IS (1) IS4781A (de)
MX (1) MX9805181A (de)
NO (1) NO311022B1 (de)
NZ (1) NZ324373A (de)
OA (1) OA10701A (de)
PE (1) PE87598A1 (de)
PL (1) PL327629A1 (de)
PT (1) PT876392E (de)
SI (1) SI0876392T1 (de)
SK (1) SK89198A3 (de)
TR (1) TR199801247T2 (de)
TW (1) TW498072B (de)
WO (1) WO1997024365A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000513380A (ja) * 1997-06-30 2000-10-10 グラクソ、グループ、リミテッド 化合物
GB9909229D0 (en) * 1999-04-23 1999-06-16 Glaxo Group Ltd Enantiomers of mercapto lactones and processes for their synthesis
GB0017988D0 (en) * 2000-07-21 2000-09-13 Glaxo Group Ltd Novel process
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6787532B2 (en) 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
CA2417826A1 (en) * 2000-08-05 2002-02-14 Glaxo Group Limited 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
AR033290A1 (es) * 2001-04-30 2003-12-10 Glaxo Group Ltd Derivados antiinflamatorios de androstano
EP1395604B1 (de) * 2001-06-12 2008-06-25 Glaxo Group Limited Neue anti inflammatorische 17.alpha.-heterozyklische ester von 17.beta.-carbothioat androstan derivativen
WO2003018575A1 (en) * 2001-08-24 2003-03-06 Wyeth Holdings Corporation 5-substituted-3(2h)-furanones useful for inhibition of farnesyl-protein transferase
GB0125259D0 (en) * 2001-10-20 2001-12-12 Glaxo Group Ltd Novel compounds
GB0127160D0 (en) * 2001-11-12 2002-01-02 Glaxo Group Ltd Novel compounds
WO2003042229A1 (en) * 2001-11-12 2003-05-22 Glaxo Group Limited Non-aromatic heterocyclic esters of furan-2-one-esters of 17.beta.-carboxyl or 17.beta.-carbothio glucocorticoids
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
AU2004226318B2 (en) * 2003-04-04 2008-06-05 Xellia Pharmaceuticals Aps Process for the preparation of steroidal carbothioic acid derivatives and intermediates
EP1466920A1 (de) * 2003-04-04 2004-10-13 Alpharma APS Verfahren zur Herstellung von steroidal 17 beta-carbothioates
WO2005097133A1 (en) * 2004-04-01 2005-10-20 F. Hoffmann-La Roche Ag Use of a trioxopyrimidine for the treatment and prevention of bronchial inflammatory diseases
PT103202B (pt) 2004-10-19 2011-01-27 Hovione Farmaciencia S A Processo para a esterificação de um ácido carbotiótico
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
TWI374147B (en) * 2006-01-27 2012-10-11 Sun Pharma Advance Res Company Ltd Novel 11β-hydroxyandrosta-4-ene-3-ones
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
CN103087137A (zh) * 2011-11-07 2013-05-08 天津金耀集团有限公司 一种21位为硫代烃基的糖皮质激素
JPWO2023210608A1 (de) 2022-04-28 2023-11-02
EP4635969A4 (de) * 2022-12-16 2026-06-10 Tianjin Pharmaceutical Biotechnology Co Ltd Neues glucocorticoid, verfahren zu seiner herstellung und seine verwendung
WO2025256615A1 (zh) * 2024-06-14 2025-12-18 津药药业股份有限公司 新型糖皮质激素的晶型

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093721A (en) * 1974-08-30 1978-06-06 Glaxo Laboratories Limited Pharmaceutical compositions of 6α,9α-difluoro-androst-4-ene-17β-carboxylates and derivatives thereof
US4188385A (en) 1978-04-05 1980-02-12 Syntex (U.S.A.) Inc. Thioetianic acid derivatives
SE8306370D0 (sv) 1983-11-18 1983-11-18 Draco Ab Novel androstane-17beta-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions
IL78144A0 (en) 1985-04-04 1986-07-31 Draco Ab Novel androstane-17beta-carboxylic acid esters
US5767113A (en) * 1995-05-10 1998-06-16 The Salk Institute For Biological Studies Compounds useful for concurrently activating glucocorticoid-induced response and reducing multidrug resistance

Also Published As

Publication number Publication date
GR3034564T3 (en) 2001-01-31
JP2947944B2 (ja) 1999-09-13
CN1209135A (zh) 1999-02-24
AP9801274A0 (en) 1998-06-30
PE87598A1 (es) 1999-01-15
JPH11501675A (ja) 1999-02-09
NZ324373A (en) 1999-10-28
HUP9903707A3 (en) 2000-04-28
NO311022B1 (no) 2001-10-01
EA199800484A1 (ru) 1999-02-25
AU721865B2 (en) 2000-07-13
BG102625A (en) 1999-04-30
ES2150150T3 (es) 2000-11-16
AU1140997A (en) 1997-07-28
EP0876392A1 (de) 1998-11-11
IL124938A0 (en) 1999-01-26
TW498072B (en) 2002-08-11
EP0876392B1 (de) 2000-07-05
KR19990076859A (ko) 1999-10-25
NO983004L (no) 1998-08-26
DE69609199T2 (de) 2001-03-01
WO1997024365A1 (en) 1997-07-10
TR199801247T2 (xx) 1998-11-23
PL327629A1 (en) 1998-12-21
US6197761B1 (en) 2001-03-06
PT876392E (pt) 2000-12-29
CZ207498A3 (cs) 1998-11-11
NO983004D0 (no) 1998-06-26
DE69609199D1 (de) 2000-08-10
HK1012193A1 (en) 1999-07-30
ATE194356T1 (de) 2000-07-15
HUP9903707A2 (hu) 2000-03-28
BR9612309A (pt) 1999-07-13
CN1133643C (zh) 2004-01-07
CA2241728A1 (en) 1997-07-10
EE9800227A (et) 1998-12-15
IS4781A (is) 1998-06-23
EA001401B1 (ru) 2001-02-26
DK0876392T3 (da) 2000-11-06
OA10701A (en) 2002-05-21
MX9805181A (es) 1998-10-31
SI0876392T1 (en) 2000-12-31

Similar Documents

Publication Publication Date Title
US6197761B1 (en) 17β-2-oxo-tetrahydrofuranyl)-carbothioic acid ester, -carboxylic acid ester and -carboxylic acid amide androstane derivatives
KR100831534B1 (ko) 17.알파 위치에 시클릭 에스테르기를 지닌 항염증성의안드로스탄의 17.베타.-카르보티오에이트 에스테르 유도체
EP0998484B1 (de) Verfahren zur identifizierung von verbindungen mit verminderter systemischer aktivität
JP2005509642A (ja) 新規の抗炎症性アンドロスタン誘導体
US20020019378A1 (en) Compounds
EP0876393B1 (de) 21-[2-oxo-tetrahydrofuran]-thio pregnan derivative, ein verfahren zu ihrer herstellung und pharmazeutische präparate davon
EP0883628B1 (de) 17beta-(2-oxo-tetrahydrofuran-4-yl)-thio-androstane derivate (17beta-(gamma-buttersäure-lacton)-thio derivate) zur behandlung von entzündungen, pharmazeutische präparate davon und ein verfahren zu ihrer herstellung
HK1012193B (en) Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives